EUVIMEDEUVIMED entdecken
Crossref

Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors

Timo Heinrich iD, Alessia Gambardella iD, Daniel Schwarz, Carl Petersson, Jakub Gunera, Sakshi Garg, Richard Schneider, Marina Keil, Lisa Grimmeisen, Andrea Unzue Lopez, Heike Schilke, Thomas Weitzel und 18 weitere

Journal of Medicinal Chemistry · 27.11.2025 · 68 (22) · 24603-24623

DOI: 10.1021/acs.jmedchem.5c02602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 10.11.2025. Verfasst von Timo Heinrich und 29 weiteren Autor:innen. Beteiligte Einrichtung: Merck Healthcare KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany. Hauptthemen laut MEDLINE: Antineoplastic Agents, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aiming to identify novel inhibitors of YAP-TEAD-dependent transcription, we conducted a TEAD-reporter-based cellular screen, which yielded a 5-azaindole hit that significantly stabilized TEAD subtypes 2 and 4 in a thermal shift assay. During optimization, derivatives with diverse TEAD selectivity profiles were obtained, including pan-TEAD and TEAD3-sparing inhibitors. Atropisomers with stabilized binding conformations surprisingly resulted in TEAD2 selective inhibitors. Cellular potency in reporter and viability assays was enhanced through targeted structural modifications. The physicochemical and pharmacokinetic properties were improved by the introduction of heteroatoms and the reduction of aromaticity. Structure-based considerations inspired the generation of a pyrrolo-pyridinone scaffold with further optimized properties. In lung cancer xenograft studies, representatives from both substance classes demonstrated monotherapeutic antitumor activity. For one selected example, the combination effect with the KRASG12C inhibitor sotorasib was demonstrated in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsTranscription FactorsHumansAnimalsStructure-Activity RelationshipCell Line, TumorMiceLung NeoplasmsXenograft Model Antitumor AssaysTEA Domain Transcription FactorsMice, Nude

Substanzen

Antineoplastic AgentsTranscription FactorsTEA Domain Transcription Factors

Autor:innen und Institutionen

  • Merck Healthcare KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany.
  • iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2781-901 Oeiras, Portugal.

ORCID-Profile: Timo Heinrich, Alessia Gambardella, Pedro M F Sousa, Tiago M Bandeiras

Zitieren

APA

Heinrich, T., Gambardella, A., Schwarz, D., Petersson, C., Gunera, J., Garg, S., Schneider, R., Keil, M., Grimmeisen, L., Unzue Lopez, A., Schilke, H., Weitzel, T., Kolb, C., Diehl, P., Doerfel, B., Anlauf, U., Reither, V., Rettig, C., Opelt, B., …, & Wienke, D. (2025). Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors. Journal of Medicinal Chemistry, 68(22), 24603-24623. https://doi.org/10.1021/acs.jmedchem.5c02602

Vancouver

Heinrich T, Gambardella A, Schwarz D, Petersson C, Gunera J, Garg S, et al. Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors. Journal of Medicinal Chemistry. 2025;68(22):24603-24623. doi:10.1021/acs.jmedchem.5c02602

BibTeX
@article{Heinrich2025,
  author = {Heinrich, Timo and Gambardella, Alessia and Schwarz, Daniel and Petersson, Carl and Gunera, Jakub and Garg, Sakshi and Schneider, Richard and Keil, Marina and Grimmeisen, Lisa and Unzue Lopez, Andrea and Schilke, Heike and Weitzel, Thomas and Kolb, Christian and Diehl, Patrizia and Doerfel, Benjamin and Anlauf, Uwe and Reither, Vivian and Rettig, Corinna and Opelt, Beate and Delp, Andrea and Wildner, Nicole and Musil, Djordje and Friedrich, Erik and Burgdorf, Lars and Fuchss, Thomas and Albers, Lisa and Sousa, Pedro M F and Freire, Filipe and Bandeiras, Tiago M and Wienke, Dirk},
  title = {Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {22},
  pages = {24603--24623},
  doi = {10.1021/acs.jmedchem.5c02602}
}
Kostenlos starten →